BOSULIF 100mg film-coated tablets PFIZER
Active substance: bosutinib
Indicated for: chronic myeloid leukemia
Find medicines for human use by name or active substance.
Browse by initial
561–580 of 789 medicines
Active substance: bosutinib
Indicated for: chronic myeloid leukemia
Active substance: bosutinib
Indicated for: chronic myeloid leukemia
Active substance: bosutinib
Indicated for: chronic myeloid leukemia
Active substance: bosutinib
Indicated for: chronic myeloid leukemia
Active substance: bosutinib
Indicated for: chronic myeloid leukemia
Active substance: bosutinib
Indicated for: chronic myeloid leukemia
Active substance: botulinum toxin type A
Indicated for: spasticity; dystonias; neuromuscular disorders
Active substance: botulinum toxin type A
Indicated for: spasticity; dystonias; neuromuscular disorders
Active substance: botulinum toxin type A
Indicated for: spasticity; dystonias; neuromuscular disorders
Active substance: botulinum antitoxin
J06AA04 Antiinfectives for systemic use | Immune sera
Indicated for: botulism
Active substance: botulinum antitoxin
J06AA04 Antiinfectives for systemic use | Immune sera
Indicated for: botulism
Active substance: teriflunomide
Indicated for: multiple sclerosis
Active substance: teriflunomide
Indicated for: multiple sclerosis
Active substance: glatiramer acetate
Indicated for: multiple sclerosis
Active substance: encorafenib
Indicated for: melanoma; colorectal cancer
Active substance: encorafenib
Indicated for: melanoma; colorectal cancer
Active substance: Tc 99m - exametazime
V09AA01 Various | Central nervous system | Technetium (99mtc) compounds
Indicated for: diagnostic imaging
Active substance: temozolomide
L01AX03 Antineoplastic and immunomodulating agents | Alkylating agents | Other alkylating agents
Indicated for: malignant glioma
Active substance: temozolomide
L01AX03 Antineoplastic and immunomodulating agents | Alkylating agents | Other alkylating agents
Indicated for: malignant glioma
Active substance: temozolomide
L01AX03 Antineoplastic and immunomodulating agents | Alkylating agents | Other alkylating agents
Indicated for: malignant glioma
WHO (World Health Organization): Any substance or product that is used or is intended to be used to alter a physiological system or a pathological condition in the recipient's benefit.
Medicinal product: A substance or combination of substances used to treat or prevent disease, to restore, correct or modify physiological functions through pharmacological, immunological or metabolic action, or to make a medical diagnosis.
Active ingredient: A substance used in a medicine to produce a pharmacological, immunological or metabolic effect that restores, corrects or modifies physiological functions.
Excipients: Ingredients in a medicine other than its active substance. They can help stabilise the medicine or deliver the active substance to its intended site of action.
Original medicine: A medicine first authorised on the basis of a full dossier documenting its quality, safety and efficacy. It may serve as the reference medicine for a generic product.
Generic medicine: A medicine developed to be equivalent to an authorised reference medicine. It contains the same active substance or substances and is used at the same doses to treat the same diseases. Its inactive ingredients, name, appearance and packaging may differ.